The ability of artificial intelligence to predict life expectancy in oncology is the ‘holy grail’ of the sector. Panellists discussed this and where else AI is having an impact on complex care at HBI 2020.
Most of the ongoing research into healthcare AI is in the clinical space. However, there are plenty of non-clinical tasks, like the protocols and positioning of MRIs, in which AI can boost productivity by 30-50%.
Non-COVID lab volumes reached their pre-pandemic levels in Q3. But does the pandemic signal the end of the sector's reliance on M&A, and what are the implications of new B2C markets? Operators Unilabs, amedes, Medicover and Dr Lal Pathlabs, B2C platform Daslab and supplier Abbott discussed all this and more at HBI 2020's 'Diagnostics: Opportunities and Challenges' & 'A new global consumer market?' sessions.
Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.
The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.
Curagita-backed Deutsche Radiologienetz AG (DeRaG), one of the first movers in consolidating the German imaging market, will soon bring in a new investor, HBI can reveal. Meanwhile, ongoing investigations into the founder of Med 360°, the largest player in the market, may raise questions over the future of one of its minority shareholders.
NHS England should cut its spending on imaging outsourcing and set up community blood-collection points, recommends a review of diagnostic services for the health service. It says the estimated cost of outsourcing is £160m but results from the largest players suggest it's a lot more.
What can you do with AI and big data today and what will be possible within three years? Why has adoption been slower than you might have expected? And what sort of role should health care providers look to play? HBI gets an expert view from digital, technology and business strategy expert Klaus Boehncke, partner at L.E.K. Consulting, who is chairing the Best Practice Workshop: Delivering Digital Excellence: A Framework for Success at HBI 2020 in two weeks.
With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.
South African hospital group Life Healthcare has sold its Polish subsidiary Scanmed to CEE private equity investor Abris for PLN 340m ($91m) but has had to impair the asset by nearly half as the offer came in below the book value.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
